These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 5147985
1. [Changes in some hemodynamic indices and the contractile state of the myocardium during infusion of dopamine in man]. Di Segni E, Capestro F, Curzi G, Di Luzio V, Purcaro A, Soro A, Di Giuseppe F. Boll Soc Ital Cardiol; 1971; 16(10):611-4. PubMed ID: 5147985 [No Abstract] [Full Text] [Related]
2. Dopamine--clinical uses of an endogenous catecholamine. Goldberg LI. N Engl J Med; 1974 Oct 03; 291(14):707-10. PubMed ID: 4604342 [No Abstract] [Full Text] [Related]
3. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock]. Döring D, Fleischmann HJ, Heunisch K, Köhler H, Trenckmann H. Z Gesamte Inn Med; 1971 Dec 15; 26(24):759-63. PubMed ID: 5152441 [No Abstract] [Full Text] [Related]
4. Dopamine: new uses for an old drug. Dipalma JR. Am Fam Physician; 1975 Apr 15; 11(4):149-51. PubMed ID: 1119364 [No Abstract] [Full Text] [Related]
5. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine. El Mokhtari NE, Arlt A, Meissner A, Lins M. Eur J Med Res; 2007 Nov 05; 12(11):563-7. PubMed ID: 18024265 [Abstract] [Full Text] [Related]
6. [Treatment of cardiogenic shock by simultaneous intravenous injection of dopamine and nitroglycerin]. Sabin G, Flenker I, Klüsener W, Neuhausen P, Ricken D. Verh Dtsch Ges Inn Med; 2007 Nov 05; 83():209-11. PubMed ID: 417502 [No Abstract] [Full Text] [Related]
7. [Treatment of irreversible heart decompensation and cardiogenic shock with glucagon]. Bruni B. Minerva Cardioangiol; 1972 Nov 05; 20(7):419-27. PubMed ID: 5050748 [No Abstract] [Full Text] [Related]
8. [Left ventricular systolic intervals as indices of the pharmacological effect of intravenous administration of digoxin and their correlation with blood levels of the drug]. De Bernardi A, Gastaldi L, Cottino AM, Rusconi O, Zardini P. Boll Soc Ital Cardiol; 1975 Nov 05; 20(11):1505-11. PubMed ID: 1234449 [No Abstract] [Full Text] [Related]
9. [Long-term use of dopamine in shock in patients with massive thromboembolism of the pulmonary artery]. Parkhomenko AN, Sirenko IuN. Vrach Delo; 1989 Mar 05; (3):43-5. PubMed ID: 2750118 [No Abstract] [Full Text] [Related]
15. [Dopamine in cardiogenic shock]. Wujanz G. Med Klin; 1976 Sep 17; 71(38):1534-8. PubMed ID: 979867 [No Abstract] [Full Text] [Related]
16. [Renal and hemodynamic effects of dopamine in chronic heart failure]. Bianchi C, Beregovich J, Lewitt B. Rev Med Chil; 1974 Jun 17; 102(6):417-21. PubMed ID: 4471408 [No Abstract] [Full Text] [Related]
17. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine. Goldberg LI, Hsieh YY, Resnekov L. Prog Cardiovasc Dis; 1977 Jun 17; 19(4):327-40. PubMed ID: 12536 [No Abstract] [Full Text] [Related]
18. [Cardiotonic effects of glucagon]. Robert M, Humair L. Schweiz Med Wochenschr; 1970 Aug 01; 100(31):1345-52. PubMed ID: 5513359 [No Abstract] [Full Text] [Related]